Dr. Richard Shubin
Dr. Richard Shubin is a neurologist in Arcadia, California and is affiliated with multiple hospitals in the area, including Huntington Memorial Hospital and Methodist Hospital of Southern California. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice for 33 years.

Dr. Shubin graduated from Stanford University in 1977 with a B.S. in Chemistry. He subsequently attended the University of Pittsburgh where he graduated with a M.A. in Philosophy in 1981 and an M.D. in 1982. He then interned in Medicine at Los Angeles County-USC. Dr. Shubin completed a residency in Neurology, and then a Fellowship in Neuro-Immunology and Virology at USC. Dr. Shubin entered private practice in Neurology in Arcadia in 1988. Dr. Shubin's interest in Sleep Medicine began while in medical school at the University of Pittsburgh. He began his training in sleep under the auspices of Dr. David Kupfer and Charles Reynolds. Dr. Shubin has had a continued interest in sleep. He became board certified by the American Academy of Sleep Medicine in 1994, and subsequently obtained special qualifications in sleep medicine through the American Academy of Psychiatry and Neurology in 2009. Dr. Shubin, in addition, has been involved in multiple phase 2 and 3 clinical trials in sleep medicine for the past twenty years.


Stanford University - Stanford, CA
B.S. Chemistry - 1976

University of Pittsburgh Pittsburgh, Pennsylvania
M.A. Philosophy - 1980
School of Medicine
M.D. - 1982

Certifications & Licensure

American Board of Psychiatry and Neurology
Certified in Neurology

American Board of Psychiatry and Neurology
Certified in Sleep Medicine

CA State Medical License
Active through 2015


  1. Reynolds, C.F., Shubin, R.A., Coble, P.A., Kupfer, D.J. Diagnostic classification of sleep disorders: Implications for psychiatric practice, J. Clinical Psychiatry 41: 296-299, 1981.
  2. Stohlman, S.A., Sussman, G.A., Matsushima, G.K., Shubin, R.A., Erlich, S.S., Delayed-type hypersensitivity response in the central nervous system during JHM virus infections requires viral specificity for protection, J. Neuroimmunolgy 19: 255-268, 1877.
  3. Fleming, J.O., Shubin, R.A., Casteel, N., Stohlman, S.A., Monoclonal antibodies to matrix protein of mouse hepatitis virus will protect mice from fatal encephalitis, J. Virology 168: 162-167, 1989.
  4. Sussman, M.S., Shubin, R.A., Kyuwa, S., Stohlman, S.A., T-cell mediated clearance of mouse hepatitis virus JHM from the central nervous system, J. Virology 63: 3051-3056, 1989.
  5. Shubin, R.A., Sussman, M.A., Fleming. J.O., Stohlman, S.A., Relapsing encephalomyelitis following transfer of partial immunity to JHM virus, Microbial Pathogenesis 8: 305-314, 1990.
  6. Waters, C.H., Takahashi. H., Wilkelmsen, K.C., Shubin, R.A., Snow, B.I., Nygaard, T.G., Moskowits, C.B., Fahn, S., Calne, D.B., Phenotypic expression of x-linked dystonia parkinsonism (lubag) in two women, Neurology 43: 1555-1558, 1993.
  7. Thirumalai, S. and Shubin R.A., Successful treatment of stroke in a child using rTPA, J. Child Neurology 15 (8): 558, 2000.
  8. Thirumalai, S. and Shubin, R.A., Use of citralopram for difficult cataplexy, Sleep Medicine 1: 313-316, 2000.
  9. Thirumalai, S. and Shubin R.A., and Robinson, R.: Rapid Eye Movement Sleep Behavior Disorder in children with autism, J. Child Neurology 17 (3): 173-178, 2002.
  10. Esmaili, D.D., Shubin, R.A., Waters, C. H., and Sadun, A. A., Eye movement abnormalities in X-linked Dystonia-Parkinsonism (Lubag). J. Neuro-Ophalmalogy 24(2): 188 – 189, 2004.
  11. Brandes, D.W., Bigley, K., Hornstein W., Cohen, H., Au, W., and Shubin, R. Alleviating flu-like symptoms with dose titration and analgesics in MS patients on intramuscular Beta-1a therapy: A pilot study. Current Medical Research and Opinions 23(7): 1667 – 1672, 2007.
Share by: